Global Dermatophytic Onychomycosis Market 2016-2020

SKU ID : TNV- 10278408

Publishing Date : 17-Feb-2016

No. of pages : 57

PRICE
2500
4000

  • About Dermatophytic Onychomycosis

    Dermatophytic onychomycosis is a fungal infection of the nail plate, nail bed, and, in some cases, the skin surrounding the nail plate. It is caused by yeast, dermatophytes, and molds; dermatophytes account for 90% of all cases. The fungus, especially Trichophyton rubrum, Trichophyton mentagrophytes, and Epidermophyton floccosum, infects the skin, hair, or nails. It is often perceived by people to be an active and contagious infection. Onychomycosis may persist or worsen if not treated. The fungi that cause onychomycosis exist in common sites such as floors, soil, socks, and shoes. Therapies for onychomycosis include debridement and drugs. Debridement is time consuming and minimally effective in eradicating the fungal infection. Systemic drug treatment is most effective in treating onychomycosis.

    Technavio’s analysts forecast the global dermatophytic onychomycosis market to grow at a CAGR of 7.44% during the period 2016-2020.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global dermatophytic onychomycosis market for 2015-2020. To calculate the market size, the report considers revenue generated from the sales of branded, generic, and off-label drugs used to treat and prevent onychomycosis.

    The market is divided into the following segments based on geography:
    • APAC
    • EMEA
    • Americas

    Technavio's report, Global Dermatophytic Onychomycosis Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    • Anacor Pharmaceuticals
    • Galderma
    • Janssen Biotech
    • Novartis
    • Valeant Pharmaceuticals

    Other prominent vendors
    • Abeona Therapeutics
    • Allergan
    • Elorac
    • GlaxoSmithKline
    • Hexima
    • Hisamitsu Pharmaceutical
    • Mayne Pharma
    • MediQuest Therapeutics
    • Meiji Seika Pharma
    • Merz Pharma
    • Moberg Pharma
    • NanoBio
    • NovaBiotics
    • Nuvo Research
    • Pfizer
    • Polichem
    • Promius Pharma
    • Sanofi
    • Seren Pharmaceuticals
    • Taro Pharmaceutical
    • Topica Pharmaceuticals
    • Viamet Pharmaceuticals

    Market driver
    • Increase in R&D
    • For a full, detailed list, view our report

    Market challenge
    • Adverse effects and limited efficacy of drugs
    • For a full, detailed list, view our report

    Market trend
    • Increased focus on combination therapies
    • For a full, detailed list, view our report

    Key questions answered in this report
    • What will the market size be in 2020 and what will the growth rate be?
    • What are the key market trends?
    • What is driving this market?
    • What are the challenges to market growth?
    • Who are the key vendors in this market space?
    • What are the market opportunities and threats faced by the key vendors?
    • What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

    Frequently Asked Questions



    This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

    • By product type
    • By End User/Applications
    • By Technology
    • By Region

    The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
    market Reports market Reports